MetaVia Inc. Ordinary Shares MTVA 深 沪
已收盘 12-26 16:00:00 美东时间
9.19
-0.570
-5.84%
华盛通- 最 高9.81
- 今 开9.81
- 成交量 1.35万股
- 最 低 9.12
- 昨 收 9.76
- 总市值 2122.06万
- 52周最高 30.25
- 市盈率 静 --
- 换手率 0.58%
- 52周最低 6.05
- 委 比 14.29%
- 总股本 230.91万
- 历史最高 1527900.00
- 量 比 0.34
- 振 幅 7.07%
- 历史最低 6.05
- 每 手 1
- 风险率 5.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement
CAMBRIDGE, Mass., Dec. 22, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that on ...
12-22 21:31
Why Confluent Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Shares of Confluent Inc (NASDAQ:CFLT) rose sharply in pre-market trading. Inter...
12-08 18:26
MetaVia Announces 1-For-11 Reverse Stock Split Of Its Common Stock, Effective December 4
MetaVia Inc. (NASDAQ:MTVA) ("MetaVia" or the "Company"), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a 1-for-11 reverse stock split of its common stock, par
12-02 21:47
MetaVia Q3 EPS $(0.14) Beats $(0.25) Estimate
MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.25) by 43.78 percent. This is a 74.55 percent increase over losses of $(0.55) per share from the same
11-06 21:41
MetaVia To Present New Phase 1 And Pre-clinical Data On DA-1726 In Two Poster Presentations At ObesityWeek 2025; New Phase 1 PK Data Support Once-Weekly Dosing; Clinically Meaningful Weight Loss Observed Without Dose Titration
MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will present new Phase 1 and pre-clinical data on DA-1726, a novel, dual
11-05 05:28
MetaVia To Present Vanoglipel Data For MASH At AASLD, Highlighting Hepatoprotective And Metabolic Effects
MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data on Vanoglipel (DA-1241), a novel
10-27 20:43
MetaVia Announces Poster Presentations on DA-1726 at ObesityWeek® 2025
CAMBRIDGE, Mass., Oct. 20, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that two...
10-20 20:31
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference
CAMBRIDGE, Mass., Oct. 14, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Pre...
10-14 20:31
Why Webtoon Entertainment Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
Shares of Webtoon Entertainment Inc (NASDAQ:WBTN) rose sharply in pre-market tr...
09-16 17:41
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Check-Cap (NASDAQ:CHEK) stock rose 25.5% to $2.66 during Monday's afte...
09-16 05:06
